次に

自動再生

The role of chemotherapy in Hodgkin lymphoma

0 ビュー • 06/26/23
シェア
埋め込む
administrator
administrator
加入者
0

Yago Nieto, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of chemotherapy in Hodgkin lymphoma (HL) treatment, which is typically employed in combination with novel agents such as brentuximab vedotin or checkpoint inhibitors. However, Prof. Nieto highlights that frail patients may require alternative chemotherapy-free approaches. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

もっと見せる
0 コメント sort 並び替え
フェイスブックのコメント

次に

自動再生